OSCR

Ursodeoxycholic acid mitigates cerebral ischemia/reperfusion injury by inhibiting thrombin-induced lipid peroxidation through activation of ALDH3A1.

Overview

Authors: Anqi Liu1,2, Tongling Yang1,2, Zhixian Li2, Ruyue Luo2, Chunyu Zhu2, Siyu Du2, Wenli Chen3, Jialin Duan1,2
ORCID iDs: Jialin Duan
  1. Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, Shaanxi, China
  2. Institute of Medical Research, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an, Shaanxi, China
  3. Department of Rehabilitation Medicine, ZhongDa Hospital Southeast University, Nanjing, Jiangsu, China
Journal: Redox biology, volume 95, article 104253
Dates: received 28 March 2026; accepted 8 June 2026; published online 8 June 2026; in print September 2026
Type: Research article · Language: English
License: CC BY-NC
Identifiers: DOI 10.1016/j.redox.2026.104253 · PMID 42263415 · PMCID PMC13273212 · OpenAlex W7163878877
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: mouse (organism), stroke (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: Ursodeoxycholic acid (UDCA), Ischemic stroke, Thrombin, Lipid peroxidation, Ferroptosis, TGR5-PKA-ALDH3A1 signaling
MeSH: Aldehyde Dehydrogenase*, Brain Ischemia*, Lipid Peroxidation*, Reperfusion Injury*, Thrombin*, Ursodeoxycholic Acid*, Animals, Disease Models, Animal, Ferroptosis, Infarction, Middle Cerebral Artery, Male, Mice, Neurons, Signal Transduction (* major topic)
Topic: Antioxidant Activity and Oxidative Stress (Biochemistry, Medicine), according to OpenAlex
Funding: National Natural Science Foundation of China (81903832); Shaanxi University of Chinese Medicine (KF202304); Fundamental Research Funds for the Central Universities (D5000210799); China Postdoctoral Science Foundation (2022M720722); Jiangsu Commission of Health (BJ24014); Key Research and Development Projects of Shaanxi Province (2022SF-182)
Citations: not cited yet (Europe PMC); 58 references in the paper

Abstract

Thrombin accumulation following ischemic stroke (IS) promotes lipid peroxidation and ferroptosis to exacerbate tissue injury; however, effective interventions targeting this pathological process remain limited. Although bile acids (BAs) have demonstrated potential benefits against IS, their alterations and specific roles in IS pathogenesis are still poorly understood.

This study was designed to further validate the detrimental effects of thrombin in neuronal injury, investigate BA profile changes in an IS model, and elucidate the underlying mechanisms.

Serum and cerebral bile acid profiles in a mouse middle cerebral artery occlusion (MCAO) model were analyzed. Infarct volume, neurological deficits, lipid peroxidation, and ferroptosis were assessed. RNA sequencing was employed to explore potential mechanisms, followed by verification using pharmacological inhibitors.

Results showed that MCAO induced upregulation of thrombin and its receptor PAR1 in neurons, leading to lipid peroxidation, ferroptosis, and subsequent neuronal injury. Bile acid profiles in brain tissues were significantly altered, and ursodeoxycholic acid (UDCA) levels were negatively correlated with infarct size. Furthermore, UDCA supplementation alleviated thrombin-induced neuronal lipid peroxidation, restored mitochondrial function, suppressed ferroptosis, and improved neurological outcomes. Mechanistically, transcriptomic analysis revealed significant changes in arachidonic acid metabolism and aldehyde dehydrogenase 3A1 (ALDH3A1) expression. UDCA was found to upregulate ALDH3A1, thereby mitigating oxidative stress and lipid peroxidation—an effect that was reversed by ALDH3A1 inhibition. We further demonstrated that UDCA upregulated ALDH3A1 through the TGR5-PKA signaling pathway, which mediated Nrf2 nuclear translocation and its subsequent binding to the Aldh3a1 promoter. In summary, UDCA confered neuroprotection against thrombin-induced lipid peroxidation in IS through the TGR5/PKA/ALDH3A1 axis. These findings identified UDCA as a promising therapeutic candidate for IS and reveal a novel signaling mechanism underlying its neuroprotective effects.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Data links

Data availability

Data will be made available on request. RNA-seq data have been uploaded to the Sequence Read Archive (SRA): https://www.ncbi.nlm.nih.gov/sra. RNA-seq data: PRJNA1474982.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 8 authors, 6 keywords, 14 MeSH terms, 6 funders, 58 references.

Cite

This paper

Liu, A., Yang, T., Li, Z., Luo, R., Zhu, C., Du, S., Chen, W., & Duan, J. (2026). Ursodeoxycholic acid mitigates cerebral ischemia/reperfusion injury by inhibiting thrombin-induced lipid peroxidation through activation of ALDH3A1. Redox biology, 95, 104253. https://doi.org/10.1016/j.redox.2026.104253

BibTeX

@article{liu2026ursodeoxycholic,
author = {Liu, Anqi and Yang, Tongling and Li, Zhixian and Luo, Ruyue and Zhu, Chunyu and Du, Siyu and Chen, Wenli and Duan, Jialin},
title = {{Ursodeoxycholic acid mitigates cerebral ischemia/reperfusion injury by inhibiting thrombin-induced lipid peroxidation through activation of ALDH3A1}},
journal = {Redox biology},
year = {2026},
month = jun,
volume = {95},
pages = {104253},
publisher = {Elsevier},
issn = {2213-2317},
doi = {10.1016/j.redox.2026.104253},
url = {https://doi.org/10.1016/j.redox.2026.104253},
pmid = {42263415},
pmcid = {PMC13273212}
}

RIS

TY - JOUR
AU - Liu, Anqi
AU - Yang, Tongling
AU - Li, Zhixian
AU - Luo, Ruyue
AU - Zhu, Chunyu
AU - Du, Siyu
AU - Chen, Wenli
AU - Duan, Jialin
TI - Ursodeoxycholic acid mitigates cerebral ischemia/reperfusion injury by inhibiting thrombin-induced lipid peroxidation through activation of ALDH3A1
T2 - Redox biology
J2 - Redox Biol
PY - 2026
DA - 2026/06/08
VL - 95
SP - 104253
SN - 2213-2317
PB - Elsevier
DO - 10.1016/j.redox.2026.104253
UR - https://doi.org/10.1016/j.redox.2026.104253
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.redox.2026.104253",
"type": "article-journal",
"title": "Ursodeoxycholic acid mitigates cerebral ischemia/reperfusion injury by inhibiting thrombin-induced lipid peroxidation through activation of ALDH3A1",
"container-title": "Redox biology",
"author": [
{
"family": "Liu",
"given": "Anqi"
},
{
"family": "Yang",
"given": "Tongling"
},
{
"family": "Li",
"given": "Zhixian"
},
{
"family": "Luo",
"given": "Ruyue"
},
{
"family": "Zhu",
"given": "Chunyu"
},
{
"family": "Du",
"given": "Siyu"
},
{
"family": "Chen",
"given": "Wenli"
},
{
"family": "Duan",
"given": "Jialin"
}
],
"container-title-short": "Redox Biol",
"volume": "95",
"page": "104253",
"DOI": "10.1016/j.redox.2026.104253",
"PMID": "42263415",
"PMCID": "PMC13273212",
"ISSN": "2213-2317",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.redox.2026.104253",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
8
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1007/s10565-026-10177-0
Multi-omics analysis and experimental validation reveal the IRF7-CXCL10 axis as a master regulator of microglial PCD in ischemic stroke.
Journal: Cell biology and toxicology
In common: stroke, mouse, cellular / molecular, 2 references
[2] doi:10.1128/msystems.00149-26
Effects of gut microbiota on the susceptibility of ischemic stroke in mice.
Journal: mSystems
In common: stroke, mouse, 2 references
[3] doi:10.1186/s10020-026-01479-4
Gut-brain axis: beneficial impact of Shouchella clausii spores on fructose induced dysfunction is associated with modulation of the deoxycholic acid - TGR5 pathway.
Journal: Molecular medicine (Cambridge, Mass.)
In common: cellular / molecular, 2 references
[4] doi:10.1038/s41419-026-09021-4
ACLY alleviates cerebral ischemia/reperfusion injury by reducing oxidative stress and enhancing mitochondrial function via histone acetylation.
Journal: Cell death & disease
In common: stroke, mouse, cellular / molecular, 1 reference
[5] doi:10.1016/j.redox.2026.104210
Vespakinin-M delineates an AMPK/mTOR-arginine-TCA cycle axis to act as an immunometabolic switch in post-stroke microglia.
Journal: Redox biology
In common: stroke, mouse, cellular / molecular, 1 reference
[6] doi:10.1186/s12866-026-05013-8
Cold environment is associated with worse outcomes in ischemic stroke patients and the underlying gut microbial mechanism.
Journal: BMC microbiology
In common: stroke, mouse, 1 reference
[7] doi:10.31083/ap51694
Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice.
Journal: Alpha psychiatry
In common: mouse, cellular / molecular, 1 reference
[8] doi:10.1167/iovs.67.5.39
Sexual Dimorphism Is Associated With Corneal Nerve and Epithelial Alterations and Tear-Film Defects in Pax6 Haploinsufficiency Mouse Model.
Journal: Investigative ophthalmology & visual science
In common: mouse, cellular / molecular, 1 reference
[9] doi:10.1038/s41598-026-48278-9
Biphasic modulation of large-fiber excitability accompanied by dynamic nerve-intrinsic immune activation following CFA-induced peripheral inflammation in mice.
Journal: Scientific reports
In common: mouse, cellular / molecular, 1 reference
[10] doi:10.3389/fmed.2025.1702025
Diagnostic value of gut microbiota profiling and circulating biomarkers to predict post-stroke infection in acute ischemic stroke.
Journal: Frontiers in medicine
In common: stroke, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.